Laura J. Hamill

Laura is an experienced professional with years of expertise in global commercial operations and strategic planning. Her career history spans decades and has included diverse roles, including Executive Vice President, Worldwide Commercial Operations at Gilead Sciences. Laura also worked in various roles at Amgen, including Senior Vice President, U.S Commercial Operations. She currently serves on the board of directors of numerous companies, including Anaptysbio, Y-mAbs Therapeutics, and Scilex Holding Company.

Laura holds a BS in Business Administration from the University of Arizona.